BiotechTube
Home/CSL/Andrew Nash
AN

Andrew Nash

Chief Strategy and Business Development Officer

CSL

Roles

Chief Strategy and Business Development OfficeratCSL
Chief Scientific OfficeratOpthea

Therapeutic Areas

HematologyImmunologyCardiovascularVaccinesRare DiseasesNephrologyRespiratory

CSL Pipeline

DrugIndicationPhase
CSL112Acute Coronary SyndromePhase 3
CSL312Hereditary AngioedemaPhase 3
EteplirsenDuchenne Muscular DystrophyCommercial
Hemgenix (CSL222)Hemophilia BCommercial
CSL200Wilson DiseasePhase 1/2
Albumin ProductsMultiple Critical Care IndicationsCommercial
Immunoglobulin TherapiesPrimary ImmunodeficienciesCommercial
Factor VIII ProductsHemophilia ACommercial

Leadership Team at CSL

PP
Paul Perreault
Chief Executive Officer and Managing Director
JL
Joy Linton
Chief Financial Officer
DB
Dr. Bill Mezzanotte
Chief Medical Officer
KE
Karen Etchberger
Chief Operating Officer
SP
Sunny Patel
President, CSL Behring
RS
Raja Singham
President, Seqirus
CC
Christine Carnes
Chief Human Resources Officer
CC
Carolyn Conti
Chief Legal Officer and Company Secretary
View full CSL profile